What is NeoGenomics's operating cash flow?

NeoGenomics (NEO) reported operating cash flow of -$8.14M in Q1 2026.

How has NeoGenomics's operating cash flow changed year-over-year?

NeoGenomics's operating cash flow increased by 67.9% year-over-year, from -$25.33M to -$8.14M.

What is the long-term trend for NeoGenomics's operating cash flow?

Over 2 years (2021 to 2025), NeoGenomics's operating cash flow has grown at a -55.8% compound annual growth rate (CAGR), from -$26.72M to $5.23M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

NeoGenomics NEO Operating Cash Flow

Operating Cash Flow at other companies

Labcorp HoldingsLH

$191.5M+935%

Quest DiagnosticsDGX

$278M-11.5%

Personalis, Inc.PSNL

-$22.48M-25.1%

Guardant HealthGH

-$65.62M-4.7%

Natera, Inc.NTRA

$40.17M-9.6%

Tempus AI, Inc.TEM

-$73.28M+30.6%

Other financials

Income statement

See full

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

See full

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.68B-21.0%

Enterprise value$1.6B-5.6%

P/S2.3×-0.9×

Profitability

See full

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's operating cash flow?: NeoGenomics (NEO) reported operating cash flow of -$8.14M in Q1 2026.
How has NeoGenomics's operating cash flow changed year-over-year?: NeoGenomics's operating cash flow increased by 67.9% year-over-year, from -$25.33M to -$8.14M.
What is the long-term trend for NeoGenomics's operating cash flow?: Over 2 years (2021 to 2025), NeoGenomics's operating cash flow has grown at a -55.8% compound annual growth rate (CAGR), from -$26.72M to $5.23M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.